
How leaders can future-proof their business
Future-proofing is investing in your business, your offerings, and your relationships rather than trying to anticipate specific challenges. At Sollis Health, a 24/7 concierge medical membership, our guiding star is future-proofing by pioneering new ways to elevate and transform healthcare for our members, providers, and community.
Build for adaptability, not predictability
With its rigid structure, extensive financial projections, and reliance on outdated market analyses, the traditional business plan was designed for a world that no longer exists. Rather than boxing themselves in with an inflexible growth strategy, the businesses that prioritize data-driven decision making, lean operational structures, and empowered teams create more opportunities for innovation, even in today's unpredictable business climate.
I've seen this with Sollis Health, where we've found that working to meet the needs of a growing, mobile membership base has given us the freedom to be more responsive to our members' needs. For example, after we saw that many of our New York-based members were regularly visiting our new Palm Beach location, we quickly opened a Boca Raton location because we maintain a robust list of target markets and available real estate. This foresight not only provided more convenience for our local members but strengthened our regional offerings with more comprehensive staffing and services.
Invest in long-term relationships, not just short-term wins
When market volatility rises, trust among your customers, your employees, and your business partners becomes even more valuable. Whether you're expanding member services, prioritizing employee culture, or exploring exciting new campaigns with your partners, investing in your people—whomever they might be—is a future-proofing tactic that builds loyalty across the board.
When I led global strategy and operations at Starwood Preferred Guest, the award-winning hotel loyalty program (now part of Marriott Bonvoy), we invested in 'ambassador service' for our most frequent guests—those staying 100+ nights per year. Each member enjoyed access to a dedicated ambassador to help navigate reservations and service requests, anticipate their needs, and even 'surprise and delight' on special stays, like stocking a member's room with plush dolls for her kids when she redeemed points to treat her family to a Disney World vacation. And if a longtime loyal member didn't spend the requisite number of nights with us in a given year due to extenuating circumstances, the ambassador was empowered to make a proactive exception to maintain ambassador service for another year. With this investment, Starwood made its most important members feel recognized and valued, thereby creating more opportunities for loyalty in the long term.
Make customer experience your competitive edge
In premium sectors especially, customer expectations are rising even as conditions become more uncertain. The pressure to differentiate has never been higher, but it's more than possible to rise to these challenges with a focus on personalization, service continuity, and care that goes beyond the transactional.
At Peloton, we leveraged the power of community to enhance the customer experience. We cultivated online spaces for members to connect outside of class, from scheduling workouts to drive shared accountability, to celebrating fitness milestones together. We even hosted in-person events to bring members together IRL, from hosting group rides and runs at our production studios to instructor meet-and-greets at each new showroom. I still remember a massive line of members decked out in Peloton gear snaking through Washington's Bellevue Square in 2017 to meet instructor Cody Rigsby. We even hosted an annual Peloton 'Homecoming,' a sold-out event in New York City that brought together 3,000 of our most passionate members, cementing their loyalty to the brand.
When it comes to member experiences, it's little things—and they all add up. Whatever your industry, customer experience will continue to be the core of your differentiation. The businesses that serve customers deeply and in obsessive detail will not only outlast economic uncertainty, but ultimately thrive.
Leadership with purpose and clarity
The antidote to uncertainty is not certainty—it's clarity of mission and agility of execution. As business leaders, we must foster cultures that welcome change while remaining steadfast in our commitment to value. You can't future-proof your industry, but if you prioritize adaptability, long-term relationships, and customer experience, you can future-proof your business.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
‘Groundbreaking' drug could slow down progression of type 1 diabetes
A 'groundbreaking' drug to slow down the development of type 1 diabetes is being tried by a handful of patients in the UK. Teplizumab, which is already approved in the US, trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average of three years. With type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas, meaning blood sugar levels are no longer regulated by the body. If blood sugar is too high or low, it can cause serious health problems and even death. People with type 1 therefore need daily insulin. Dentist and mother-of-two, Hannah Robinson, from Devon, is the first adult in the UK to try the drug in the hope it can delay the condition. She is having treatment at the Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1. A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS. The 36-year-old said: 'For me, this new drug offers more freedom and the chance to focus on my health before I have to start thinking differently and managing life as somebody needing daily insulin. 'This isn't just about what I eat or monitoring my glucose, it is also about having more control and not feeling defined by my condition. 'This treatment could potentially pave the way for a future cure for type 1 diabetes, which is incredible. I feel very lucky to be part of this.' The new drug teplizumab must be given at the earliest stage of the disease to be effective. Dr Nick Thomas, diabetes consultant and academic clinical lecturer at the University of Exeter, said: 'This new treatment represents a really exciting shift in how we manage type 1 diabetes. 'For the first time ever, we will be able to provide targeted treatment early enough in the process to alter the underlying immune process, aiming to slow down how quickly people need insulin. 'Approximately half of all type 1 diabetes cases develop in adulthood, and Hannah will be the first adult in the UK to receive this treatment. 'My hope is that in the future, we may be able to stop people with early type 1 diabetes from needing insulin at all.' Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes. The hope is more people could be offered the drug to delay type 1. Dr Lucy Chambers, head of research impact and communications at Diabetes UK, said: 'For people in the early stages of type 1 diabetes, teplizumab offers a groundbreaking opportunity to buy them precious extra years insulin-free. 'Right now, it's only available in research settings – and while the excitement is real, urgent work is still needed to ensure it reaches everyone who could benefit. 'That means securing a UK licence for teplizumab, establishing national screening programmes to identify people with early-stage type 1 diabetes before symptoms appear, and preparing the NHS to deliver this treatment at scale. 'Diabetes UK is proud to be at the forefront of these efforts – funding pioneering research and working closely with the NHS towards a future where immunotherapies become the first-line treatment for tackling the autoimmune attack at the root of type 1 diabetes.' Professor Richard Oram, consultant physician at the Royal Devon and professor at the University of Exeter, said: 'Excitingly, teplizumab is the first drug with the potential to delay type 1 diabetes, but needs to be given before clinical diagnosis due to high blood glucose. 'It is really important to find new and improved approaches for identifying individuals at elevated risk.'
Yahoo
39 minutes ago
- Yahoo
Samsung to buy US healthcare services company Xealth
SEOUL (Reuters) -Samsung Electronics said on Tuesday it had signed an agreement to acquire Xealth, a U.S.-based healthcare platform, as part of its efforts to expand its mobile healthcare services business. The South Korean company did not disclose the value of the transaction. Samsung said the two companies hoped to create "synergy between Samsung's advanced wearable technology and Xealth's digital health platform" which runs digital health programs and manages data linking care providers, including more than 500 U.S. hospitals, with their patients. The acquisition comes as Samsung steps up efforts to diversify beyond its core semiconductor and smartphone businesses. Samsung has been betting on the medical sector as one of its new growth engines, along with consumer audio, cooling and heating systems, and robotics. In May, Samsung Electronics agreed to buy Germany's FlaktGroup for 1.5 billion euros ($1.68 billion) as it looks to meet growing demand for cooling of data centres used for artificial intelligence projects. Samsung, led by Chairman Jay Y. Lee, said at a shareholder meeting in March that it was looking for "meaningful" deals this year to drive growth after having lagged rivals in tapping the AI chip boom led by Nvidia. Samsung earlier on Tuesday projected a far worse-than- expected 56% plunge in second-quarter operating profit due to weak AI chip sales, deepening investor concerns over the tech giant's ability to revive its struggling semiconductor business.


Washington Post
an hour ago
- Washington Post
Amazon extends Prime Day discounts to 4 days as retailers weigh tariff-related price increases
NEW YORK — Amazon is extending its annual Prime Day sales and offering new membership perks to Generation Z shoppers amid tariff-related price worries and possibly some consumer boredom with an event marking its 11th year. The e-commerce giant's promised blitz of summer deals for Prime members starts at 3:01 a.m. Eastern time on Tuesday. For the first time, Seattle-based Amazon is holding the now-misnamed Prime Day over four days; the company launched the event in 2015 and expanded it to two days in 2019.